- Methodology article
- Open Access
Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum
© Nagaoka et al; licensee BioMed Central Ltd. 2010
- Received: 5 January 2010
- Accepted: 2 June 2010
- Published: 2 June 2010
To maintain pluripotency of human embryonic stem (huES) cells in feeder-free culture it has been necessary to provide a Matrigel substratum, which is a complex of poorly defined extracellular matrices and growth factors derived from mouse Engelbreth-Holm-Swarm sarcoma cells. Culture of stem cells under ill-defined conditions can inhibit the effectiveness of maintaining cells in a pluripotent state and reduce reproducibility of differentiation protocols. Moreover recent batches of Matrigel have been found to be contaminated with the single stranded RNA virus, Lactate Dehydrogenase Elevating Virus (LDEV), raising concerns regarding the safety of using stem cells that have been cultured on Matrigel in a therapeutic setting. To circumvent such concerns, we attempted to identify a recombinant matrix that could be used as an alternative to Matrigel for the culture of human pluripotent stem cells. huES and human induced pluripotent stem (hiPS) cells were grown on plates coated with a fusion protein consisting of E-cadherin and the IgG Fc domain using mTeSR1 medium.
Cells grown under these conditions maintained similar morphology and growth rate to those grown on Matrigel and retained all pluripotent stem cell features, including an ability to differentiate into multiple cell lineages in teratoma assays. We, therefore, present a culture system that maintains the pluripotency of huES and hiPS cells under completely defined conditions.
We propose that this system should facilitate growth of stem cells using good manufacturing practices (GMP), which will be necessary for the clinical use of pluripotent stem cells and their derivatives.
- Pluripotent Stem Cell
- Embryoid Body
- Human Pluripotent Stem Cell
- hiPS Cell
The generation of human embryonic stem (huES) cells and induced pluripotent stem (hiPS) cells has been well-established [1–3]. Pluripotent cells have the potential to be used for cell therapy as well as the study of human disease and development and so offer a resource that could have substantial biomedical impact . Initially, the sustained culture of pluripotent stem cells required growth on a layer of mouse embryonic fibroblasts (MEF), which presumably provide factors that sustain cell pluripotency and viability . Recently, a variety of culture media have been established that can circumvent the need for feeder cells as long as the cells are cultured on a substratum, which is usually Matrigel . Xu et al examined various purified extracellular matrix substrates for their ability to support culture of huES cells and found that Matrigel can maintain the pluripotency of huES cells efficiently . Therefore, Matrigel has been used for feeder free culture of huES cells in most studies to date.
Matrigel is a purified gel matrix from Engelbreth-Holm-Swarm sarcoma cells that consists of a mixture of extracellular matrices, proteoglycans, and growth factors [7–9]. It is highly biologically active and closely resembles basement membrane in both consistency and activity . In addition to facilitating the culture of pluripotent stem cells, Matrigel is also used to induce cell differentiation, facilitate invasion of cancer cells, increase tumor growth, and has been used extensively to support duct formation and angiogenesis. Although acting as a viable substitute for basement membrane, Matrigel is a relatively impure preparation, with significant lot to lot variability. For the culture of huES cells, growth factor-reduced Matrigel is used . Although an improvement over the standard preparations, the levels of growth factors that remain are substantial and are likely to impact the reproducibility of the culture and controlled differentiation of pluripotent stem cells in general. Additional concerns have been raised recently due to the widespread distribution of preparations of Matrigel that were contaminated with Lactate Dehydrogenase Elevating Virus (LDEV) . Such contaminations raise serious safety issues if pluripotent stem cells are to be used for autologous cell therapy.
There has been considerable discussion over the development of ideal culture conditions for huES cells using defined matrix, defined media supplemented with recombinant proteins, together with the elimination of xenogeneic components, such as FBS or feeder cells. However, significant difficulties remain in developing fully defined huES cell culture conditions, including the need for a suitable cell surface matrix. In an attempt to overcome problems associated with the use of Matrigel, we sought to examine the feasibility of using recombinant protein as a defined substratum that could support the culture of pluripotent human stem cells. E-cadherin, a Ca2+-dependent cell-cell adhesion molecule [13, 14], is essential for intercellular adhesion and colony formation of mouse embryonic stem cells [15, 16]. Several reports suggest that E-cadherin levels in huES cells decrease during differentiation [17, 18] and so high expression of E-cadherin is characteristic of undifferentiated pluripotent stem cells. We have previously reported that mouse embryonic stem cells can be successfully maintained on surfaces coated with a fusion protein consisting of the E-cadherin extracellular domain and the IgG Fc domain (E-cad-Fc) . On E-cad-Fc-coated plates mouse ES cells do not form colonies but do retain pluripotency and can be used to generate germline-competent chimeric mice [19, 20]. We, therefore, examined whether human E-cad-Fc could substitute for Matrigel and support pluripotency of huES and hiPS cells using completely-defined culture conditions.
Maintenance of huES cells on an hE-cad-Fc-coated surface under standard culture conditions
First, we asked whether hE-cad-Fc-coated culture dishes could support propagation and maintain pluripotency of huES cells under conditions that support ES cell culture on Matrigel. In our laboratory H9 (WA09) ES cells are routinely passaged on a feeder layer of mitotically inactive embryonic fibroblasts (MEFs). Cells were harvested by manual dissection initially followed by trypsin digestion to produce a single cell suspension, transferred to plates coated with either Matrigel or hE-cad-Fc and grown in MEF-conditioned medium (MEF-CM). Since trypsin treatment reduced cell viability on both matrices, we used Accutase from the 2nd passage onward. After 7-days in culture the huES cells grown on Matrigel or hE-cad-Fc were found to be morphologically indistinguishable (Figure 1B) and this morphology was maintained for >13 passages using Accutase under both conditions. In both cases the cells had formed densely packed colonies and the individual cells had a high nuclear to cytoplasmic ratio that is typical of huES cells. We next determined whether expression of pluripotency markers could be maintained following extended culture of huES cells on hE-cad-Fc. Cells were cultured for ≥90 days on either Matrigel or hE-cad-Fc, with the cells being passaged on a weekly basis. Figures 1C and 1D show that H9 huES cells cultured on hE-cad-Fc-coated dishes maintained expression of alkaline phosphatase activity (68 passages: Figure 1C) and expression of Oct-3/4 (13 passages: Figure 1D) which was comparable to cells cultured on Matrigel. As shown in Figure 1E, FACS analyses determined that >94% of cells expressed SSEA-4, irrespective of whether Matrigel or hE-cad-Fc was used as a substrate. RT-PCR analyses revealed that huES cells cultured either on MEFs or on hE-cad-Fc maintained expression of POU5F1 (OCT-3/4), NANOG and ZFP42 (REX-1) mRNAs, which are characteristic of pluripotent stem cells (Figure 1F). Like control H9 cells cultured on Matrigel, cells cultured using hE-cad-Fc were also able to differentiate into multiple cell lineages after formation of embryoid bodies. Figure 1F shows that mRNAs that are characteristic of ectoderm (NEUROD1), mesoderm (T/BRACHYURY and GSC) and endoderm (GATA4, GATA6, AFP and SOX17) could be identified in embryoid bodies from H9 ES cells that had been cultured on either MEFs or hE-cad-Fc-coated surfaces. Importantly, none of these mRNAs were detected in huES cells cultured on hE-cad-Fc plates before embryoid body formation. From these data we conclude that hE-cad-Fc can substitute for Matrigel in supporting the extended culture and pluripotency of huES cells.
huES cells cultured under completely defined conditions
Extensive culture under feeder-free conditions, including on Matrigel, commonly results in accumulation of chromosomal abnormalities . Rosler et al reported that up to 20% of H9 cultures grown using feeder-free conditions on a Matrigel-coated surface demonstrated genetic abnormalities and that trisomy 20 is the most frequent chromosomal defect found in H1, H7 and H9 cells . We therefore examined the karyotype and performed g-banding analyses of H9 cells that had been cultured on the hE-cad-Fc-coated surface after 37 consecutive passages (>60 passages in total). No chromosomal rearrangements were identified. Of the 20 cells examined 19 had a normal diploid karyotype (Figure 2G); however, one aneuploid cell was found to have trisomy 20. Fluorescent In Situ Hybridization analysis (FISH) was therefore performed on 200 cells using probes to detect chromosomes 7 and 20. Analyses of the 200 cells revealed that all cells had a normal copy number, suggesting that the identification of the trisomy 20 by cytogenetic analysis may have been an experimental artefact or that it is an extremely rare occurrence. These data imply that even after extensive culture, the hE-cad-Fc substrate can support a stable population of pluripotent stem cells. Nevertheless, the possibility of low numbers of cells putatively harbouring trisomy 20 emphasises the need to routinely examine the karyotype of all pluripotent stem cell cultures, regardless of growth conditions.
We also used RT-PCR analyses to assess the extent of cell differentiation following extended culture in mTeSR1 on hE-cad-Fc using both immunocytochemistry and RT-PCR analysis (Figure 2E and 2F). Although Brachyury, an early marker of mesendodermal cell differentiation, was identified by immunostaining in approximately 1% of cells cultured in MEF conditioned medium on either surface (Figure 2E), this differentiation marker was not found to be expressed in cells maintained in mTeSR1 regardless of whether the surface consisted of Matrigel or hE-cad-Fc. Similarly, low levels of mRNAs that are characteristically found in mesoderm, ectoderm, and endoderm, could be detected by RT-PCR in cells cultured on Matrigel, but not when cells were cultured on hE-cad-Fc plates (Figure 2F). When cells cultured in mTeSR1 medium were removed from either the Matrigel or hE-cad-Fc plates and grown in suspension, they retained the capacity to form embryoid bodies and express lineage-enriched genes (Figure 2F), indicating that huES cells could differentiate into multiple cell types when cultured under these highly defined conditions. Finally, we examined whether pluripotency of huES cells was retained after an extended 13 passages in mTeSR1 on hE-cad-Fc coated plates by following their ability to generate teratomas in Rag2-/-Il2rg-/- mice. Nine weeks after transplantation, teratomas had formed and histological analyses revealed the presence of cells from all three germ layers (Figure 2H; panels a-g).
Plating efficiency of huES cells on an hE-cad-Fc-coated surface
The observation that huES cells could adhere to an hE-cad-Fc-coated surface, albeit with reduced efficiency compared to Matrigel, but could not adhere to an IgG-coated surface, suggested that huES cells were likely to bind to E-cad-Fc-coated plates through interactions between cell surface E-cadherin and the E-cadherin domain of hE-cad-Fc. Since E-cadherin is often targeted by proteases, we postulated that the relative reduction in adherence of huES cells to an hE-cad-Fc-coated surface compared to Matrigel may reflect the degradation of cell surface E-cadherin by Accutase. The active ingredients of Accutase are proprietary; however, it has been marketed as having both protease and collagenolytic activities. To test whether Accutase resulted in the degradation of E-cadherin, cells were harvested from Matrigel and hE-cad-Fc-coated plates using either Accutase, enzyme-free Cell Dissociation Buffer, or by scraping, and the state of E-cadherin protein examined by immunoblotting (Figure 4B). When immunoblots were probed with an antibody that recognizes the carboxyl end of E-cadherin it revealed a single 120 kDa band in cells isolated by scraping or under enzyme free conditions. In contrast to these control cells, in cells collected using Accutase the same antibody recognized additional faster migrating bands, which presumably are products of Accutase-mediated proteolysis, in addition to small amounts of the full length E-cadherin. The loss of E-cadherin on the surface of huES cells following Accutase treatment was confirmed by FACS analysis using a phycoerythrin-conjugated anti-E-cadherin antibody (Figure 4C).
The observation that enzyme-free Cell Dissociation Buffer preserved full-length E-cadherin suggested that the efficiency of adhesion of huES cells to an hE-cad-Fc-coated surface could be improved if cells were collected using enzyme-free Cell Dissociation Buffer instead of Accutase. To test this, huES cells were cultured on either Matrigel or hE-cad-Fc-coated plates and harvested using Accutase or enzyme-free Cell Dissociation Buffer. Harvested cells were then plated onto new plates containing either Matrigel or hE-cad-Fc-coated surfaces and the number of adhesive cells were counted. Figure 4D shows that, as before, harvesting cells using Accutase reduced the number of cells adhering to the E-cadherin substratum compared to Matrigel. However, when huES cells were collected using enzyme-free Cell Dissociation Buffer there was no difference in the efficiency of plating cells on either Matrigel or an hE-cad-Fc-coated surface.
We finally determined the optimum concentration required for efficient cell plating. As shown in Figure 4E, the culture surface was saturated after application of hE-cad-Fc at 15 μg/ml. The number of H9 cells adhering to the hE-cad-Fc-coated surface was found to increase in proportion to the concentration of hE-cad-Fc used for coating, with 10-20 μg/ml hE-cad-Fc producing maximal H9 adherence (Figure 4F). These results indicate that the reduced adhesion of huES cells to an hE-cad-Fc-coated surface after Accutase treatment is likely due to the degradation of cell surface E-cadherin and that enzyme-free dissociation buffer can facilitate efficient passaging of huES cells grown on plates coated with 20 μg/ml hE-cad-Fc.
Maintenance of human iPS cells on an hE-cad-Fc-coated surface without feeder cells
Although a number of defined media have been described that support pluripotent stem cell growth, most rely on the use of culture dishes coated with substrates that are relatively impure preparations of extracellular matrices. This report describes the use of highly pure recombinant hE-cad-Fc as a substitute for basement membrane that facilitates maintenance of pluripotency under completely defined conditions. Pluripotent stem cells cultured on an hE-cad-Fc-coated surface were virtually indistinguishable from those grown on a Matrigel-coated surface, including cell morphology, rate of proliferation, maintenance of an undifferentiated phenotype, and ability to differentiate into multiple cell types in both embryoid bodies and teratomas. The one difference was noted when cells were passaged using protease digestion cocktails such as Accutase, in that their adhesion efficiency was reduced; however, reduced adherence was circumvented by using enzyme-free Cell Dissociation Buffer to passage the cells. Indeed we believe that the use of enzyme-free methods to passage pluripotent stem cells has advantages, including the preservation of cell-surface proteins that can be used for FACS analyses and sorting.
Historically, integrin-mediated cell-ECM interactions have been considered essential for maintenance of stem cell pluripotency and viability [24–26]. Based on such studies, a significant effort has been devoted to finding a suitable ECM component that can maintain interactions with these cell surface receptors. In mouse ES cells, type I and IV collagen have been reported as contributing to the maintenance of pluripotency , although mouse ES cells don't appear to express α1ß1 or α2ß1 integrins, which are the predominant receptors through which cells adhere to collagen within a basement membrane. In addition, laminin-511 was also found to enable the maintenance of pluripotency of mouse ES cells through interactions with α6ß1 and α5ß1 integrins . Recently recombinant vitronectin , collagen  and laminin-511  have been reported as matrices that support human ES cells pluripotency all of which facilitate binding through interaction with integrins.
The absence of integrin binding proteins within the hE-cad-Fc substratum may indicate that integrin-mediated signalling is dispensable for stem cell maintenance. Integrin-ECM interactions predominantly act through integrin-linked kinase (ILK) or focal adhesion kinase (FAK) signalling pathways, and a subset of integrins have been shown to activate PI3K/Akt and MAPK pathways . Although E-cadherin-mediated adhesion is commonly associated with ß-catenin signalling, it also stimulates PI3K/Akt signalling at least in ovarian carcinoma cells . The Akt signalling pathway has been considered important for maintenance of pluripotency in mouse, primate, and human ES cells [34, 35]. Although further analyses are required before the exact mechanism through which the hE-cad-Fc surface can support pluripotency is fully understood, we speculate that trans-homodimerization between cell surface E-cadherin and the E-cadherin domain presented through the hE-cad-Fc surface could facilitate stem cell maintenance by activation of PI3K/Akt signalling pathway. Consistent with this reasoning, several studies have implicated a role for E-cadherin in controlling both pluripotency and differentiation of ES cells [15, 18, 36], although the mechanism through which E-cadherin regulates these processes appears to be complex.
We previously reported that using mouse E-cad-Fc as a substratum, mouse ES cells, although retaining pluripotency, transition to a mesenchymal morphology and scatter across the plate rather than forming colonies [19, 20]. In contrast, human pluripotent stem cells retain their ability to form colonies and show no evidence of undergoing an epithelial to mesenchymal transition (Figures 1B and 2A). The mechanisms underlying the different response to culture on E-cadherin substrate between mouse and human pluripotent stem cells have yet to be defined. However, human and mouse embryonic stem cells have been shown to display substantial differences in expression of transcription factors, cytokines, cell surface markers, growth factor receptors, and proteins involved in cell cycle control . These differences in gene expression between mouse and human ES cells can often explain functional distinctions between the cell types, including the independence of human ES cells on LIF for maintaining pluripotency, the ability of human but not mouse ES cells to form trophectoderm in culture, and the relatively slow rate of proliferation of human ES cells compared to that of mouse. Harb et al. demonstrated that the inhibition of Rho-ROCK pathway induces cell scattering of human ES cells , indicating that there are different mechanisms that control cytoskeletal reorganization in human and mouse ES cells. Although both mouse and human ES cells express E-cadherin, it seems possible that a subset of the myriad of proteins that interact to define E-cadherin biological activity could differ between mouse and human ES cells, and experiments to address this are currently underway.
In conclusion, we have demonstrated that hE-cad-Fc can support the viability and stem cell character of huES cells using completely defined culture conditions. We also found that like huES cells, hiPS cells could also be maintained on an hE-cad-Fc-coated surface. Progress toward generating hiPS cells that could be compatible with therapeutic procedures has been rapid. For example, several defined media that support reprogramming and hiPS culture without MEFs have been described, the avoidance of using selectable markers during reprogramming has been successful, and the need to use potentially mutagenic lentiviruses to convert somatic cells into hiPS cells has been circumvented. However, the availability of a defined substratum that avoids the possibility of animal or viral contaminants yet supports the generation and maintenance of hiPS cells has remained a challenge. We propose that recombinant hE-cad-Fc, with its ease of purification, simplicity of use, and its reproducibility, should allow the widespread replacement of Matrigel as a substratum for routine culture of human pluripotent stem cells.
The generation of human iPS cells used in the current manuscript have been described in detail elsewhere  following the procedures established by Yu et al. huES (H9 cells and H1 cells) and human iPS cells (hiPSC2a, hiPSC3a and hiPSC6a) were maintained on MEFs in DMEM/F12 (Invitrogen, Carlsbad, CA), supplemented with 1 mM L-glutamine (Millipore, Billerica, MA, http://www.millipore.com), 1% nonessential amino acids (Millipore, Billerica, MA), 0.1 μM ß-mercaptoethanol (Sigma Chemical, St. Louis, MO), 20% (vol/vol) Knockout serum replacement (KSR; Invitrogen, Carlsbad, CA) and 4 ng/mL bFGF. For feeder-free cultures, cells were cultured on a Matrigel-coated dish in medium conditioned by mitomycin C-treated MEF supplemented with 4 ng/mL bFGF or in mTeSR1 (Stemcell Technologies, Vancouver, Canada, http://www.stemcell.com). Cells were passaged with Accutase (Millipore, Billerica, MA) or enzyme-free Cell Dissociation Buffer (PBS-based: Invitrogen, Carlsbad, CA) before becoming confluent by incubating at room temperature until cells detached from the surface. For passage from Matrigel to hE-cad-Fc coated plates it was crucial to remove cells either using Cell Dissociation Buffer or minimal digestion with Accutase (<3 mins). All media contained 100 units/mL penicillin and 100 μg/mL streptomycin (Millipore, Billerica, MA). Cell karyotype and FISH analyses were performed by Cell Line Genetics, LLC (Madison, WI)
Expression of fusion protein and preparation of hE-cad-Fc-coated dishes
To construct hE-cad-Fc, the cDNA that encodes human E-cadherin extracellular domain was amplified by nested PCR with KOD plus polymerase (TOYOBO, Osaka, Japan, http://www.toyobo.co.jp) from the cDNA of A431 cells. The specific primer pairs were used for amplification: 5'- AAG CAC CTG TGA GCT TGC G -3' and 5'- AAG TCC TGG TCC TCT TCT CCG C -3' for 1st PCR; 5'- AAG CTT CCA CCA TGG GCC CTT GGA GCC GCA GC -3' and 5'- GCG GCC GCT CTT CCT ACA GAC GCC GGC GGC CCC -3' for nested PCR. The cDNA of human E-cadherin fragment and mutated mouse IgG1 Fc domain (T252M-T254S) , which has a high affinity to Protein A, were ligated with pRC/CMV (Invitrogen, Carlsbad, CA) fragment, which was digested with HindIII and XbaI to generate the expression vector "pRC-hECFC." 293T cells were transfected with "pRC-hECFC" using Lipofectamine and PLUS reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's directions. After selection of a highly expressing clone, 1C8, with 400 μg/mL G418 (Invitrogen, Carlsbad, CA), conditioned media were collected. The fusion proteins were loaded onto a rProtein A FF column (GE Healthcare Life Sciences, Pittsburgh, PA). The column was washed with 20 mM phosphate buffer (pH 7.0), and the bound proteins were eluted using 0.1 M sodium citrate (pH 2.7) followed by neutralization with a 1/5 volume of 1.0 M Tris-HCl (pH 9.0). Eluates were dialyzed against PBS containing 0.9 mM CaCl2 and 0.9 mM MgCl2 for 3 days. To prepare the hE-cad-Fc-coated surface, purified hE-cad-Fc solution was directly added to non-treated polystyrene plates at a concentration of 20 μg/ml unless otherwise described. After 2 h incubation at 37°C, plates were washed with PBS once and then cells were seeded.
Alkaline phosphatase detection and immunocytochemistry
Alkaline phosphatase activity was determined using an alkaline phosphatase detection kit (Millipore, Billerica, MA). For immunocytochemistry, cells were fixed with 8% formaldehyde/PBS solution for 10 min and made permeable with 0.2% Triton X-100 (Fisher Scientific International, Hampton, NH, http://www.fishersci.com) for 2 min at room temperature. Fixed cells were incubated with 1% BSA/PBS for 1 h at room temperature and then stained with anti-mouse Oct-3/4 polyclonal antibody (H-134; Santa Cruz Biotechnology, Santa Cruz, CA, http://www.scbt.com), anti-phospho-histone H3 (Ser10) antibody (Millipore, Billerica, MA), or anti-activated caspase-3 antibody (BD Pharmingen, San Diego, CA, http://www.bdbiosciences.com) for 2 h, followed by Alexa Fluor-conjugated secondary antibodies (Invitrogen, Carlsbad, CA) for 1 h. Nuclei were counterstained with 0.5 μg/mL DAPI (Invitrogen, Carlsbad, CA). Samples were observed by fluorescence microscopy. For BrdU staining, cells were incubated with 10 μM BrdU (Sigma-Aldrich, St Louis) for 75 min at 37°C and then fixed and permeabilized using the same method as above. The nuclear DNA was denatured by incubating in 2N HCl for 30 min at room temperature. After washing with PBS, cells were stained with anti-BrdU antibody (clone BU1/75 ICR1; Abcam, Cambridge, U.K., http://www.abcam.com), followed by Alexa Fluor-conjugated secondary antibody, as above.
Flow cytometry analysis
For analysis cell-surface SSEA-4 expression, cells were treated with Accutase (Millipore, Billerica, MA) and stained with phycoerythrin-conjugated anti-SSEA-4 antibody (Millipore, Billerica, MA). For E-cadherin expression, cells were treated with Accutase or Cell Dissociation Buffer and stained with phycoerythrin-conjugated anti-E-cadherin antibody (R&D systems, Minneapolis, MN, http://www.rndsystems.com). Stained cells were analyzed using Guava EasyCyte system (Millipore, Billerica, MA).
Total RNA was isolated with RNeasy Plus Mini Kit (Qiagen, Valencia, CA, http://www.qiagen.com). First-strand cDNA was synthesized using Moloney murine leukemia virus (M-MLV) reverse transcriptase (Invitrogen, Carlsbad, CA), and PCR was carried out with Taq polymerase in supplier's reaction buffer containing 1.5 mM MgCl2. Oligonucleotide primer sequences are available by request. Amplicons were analyzed by 2% agarose gel electrophoresis.
Adhesion and growth assays
For the adhesion assay, cells were seeded at a density of 1.0 × 105 cells/well into 24-well plates pre-coated with Matrigel, mouse IgG (Jackson Immunoresearch Laboratories, West Grove, PA, http://www.jacksonimmuno.com) or hE-cad-Fc. After 3 h of culture, medium and non-adherent cells were removed and cells were washed with culture medium. Adherent cells were stained with Cell Proliferation Reagent WST-1 (Roche Applied Science, Indianapolis, IN, http://www.roche-applied-science.com). After incubation for 2.5 h, absorbance at 450 nm was measured using a microplate reader (BioTek Instruments, Winooski, VT, http://www.biotek.com). For the cell growth assay, cells were seeded into a 96-well plate coated with hE-cad-Fc at a density of 3,000 cells/well or coated with Matrigel at a density of 1,000 cells/well. The cell number was evaluated once per day by the same method as for adhesion assay.
Teratoma formation assay
Cells were collected by Accutase treatment and injected into immunocompromised Rag2-/-Il2rg-/- mice (Taconic, Hudson, NY, http://www.taconic.com) subcutaneously or in the hind limb muscle. After 9 to 10 weeks, teratomas were surgically dissected from the mice. Samples were fixed in 4% zinc-formaldehyde and embedded in paraffin. Sections were cut at 4 μm and processed with hematoxylin and eosin staining. The Medical College of Wisconsin's IACUC approved all animal procedures used in this study.
Total protein was extracted with lysis buffer (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% Nonidet P40, 1% Triton X-100, 1 mM CaCl2). Samples were separated by electrophoresis on 12% polyacrylamide gels and electrophoretically transferred to a polyvinylidene difluoride membrane (Bio-Rad Laboratories, Hercules, CA, http://www.bio-rad.com). Blots were probed with anti-E-cadherin antibody (BD Transduction Laboratories, San Diego, CA, http://www.bdbiosciences.com) or anti-ß-actin antibody (Sigma), followed by horseradish peroxidase-conjugated secondary antibodies, and developed by SuperSignal West Pico substrate (Thermo Scientific, Waltham, MA, http://www.thermo.com).
Coating efficiency of hE-cad-Fc onto polystyrene surface
Purified hE-cad-Fc protein was labelled with peroxidase labelling kit-NH2 (Dojindo Molecular Technologies, Inc., Rockville, MD). Labelled protein was diluted with unlabelled hE-cad-Fc (1/400) and then serially diluted with PBS. Diluted samples were added to a 96-well plate and incubated for 1 h at 37°C. Surfaces were washed with PBS three times and incubated with 100 μl of tetramethylbenzidine (TMB) substrate at room temperature. After addition of 100 μl of 1N HCl, absorbance at 450 nm was measured using a microplate reader. The amount of immobilized hE-cad-Fc was calculated from a standard curve of labelled hE-cad-Fc captured by anti-mouse IgG antibody-immobilized surface.
Values are reported as means ± SD or SEM. Statistical significance was assessed using the paired Student's t-test. The probability level accepted for significance was P < 0.05.
We thank Dr. Michele Battle for helpful discussions and technical assistance for teratoma generation, Stephani Lohman for technical assistance, Dr. Paula North for histological analyses of teratomas and Dr. Bassam Wakim and Michael Pereckas for TOF-MASS analysis. Support to MN from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, as well as gifts to SAD from the Marcus Family, Phoebe R. and John D. Lewis Foundation, the Sophia Wolf Quadracci Memorial Fund, and the Dr. James Guhl Memorial Fund is graciously acknowledged.
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science. 1998, 282: 1145-1147. 10.1126/science.282.5391.1145.View ArticlePubMedGoogle Scholar
- Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007, 131: 861-872. 10.1016/j.cell.2007.11.019.View ArticlePubMedGoogle Scholar
- Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007, 318: 1917-1920. 10.1126/science.1151526.View ArticlePubMedGoogle Scholar
- Lerou PH, Daley GQ: Therapeutic potential of embryonic stem cells. Blood Rev. 2005, 19: 321-331. 10.1016/j.blre.2005.01.005.View ArticlePubMedGoogle Scholar
- Stewart MH, Bendall SC, Bhatia M: Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency. J Mol Med. 2008, 86: 875-886. 10.1007/s00109-008-0356-9.View ArticlePubMedGoogle Scholar
- Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK: Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001, 19: 971-974. 10.1038/nbt1001-971.View ArticlePubMedGoogle Scholar
- Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR: Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry. 1982, 21: 6188-6193. 10.1021/bi00267a025.View ArticlePubMedGoogle Scholar
- Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR: Basement membrane complexes with biological activity. Biochemistry. 1986, 25: 312-318. 10.1021/bi00350a005.View ArticlePubMedGoogle Scholar
- Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH: Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res. 1992, 202: 1-8. 10.1016/0014-4827(92)90397-Q.View ArticlePubMedGoogle Scholar
- Kleinman HK, Martin GR: Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 2005, 15: 378-386. 10.1016/j.semcancer.2005.05.004.View ArticlePubMedGoogle Scholar
- Taub M, Wang Y, Szczesny TM, Kleinman HK: Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc Natl Acad Sci USA. 1990, 87: 4002-4006. 10.1073/pnas.87.10.4002.PubMed CentralView ArticlePubMedGoogle Scholar
- Carlson JA, Garg R, Compton SR, Zeiss C, Uchio E: Poliomyelitis in SCID Mice Following Injection of Basement Membrane Matrix Contaminated with Lactate Dehydrogenase-elevating Virus. Proceedings of the 59th AALAS National Meeting, PS35: 9-13. 2008, November , IndianapolisGoogle Scholar
- Takeichi M: Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1994, 7: 619-627. 10.1016/0955-0674(95)80102-2.View ArticleGoogle Scholar
- Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005, 6: 622-634. 10.1038/nrm1699.View ArticlePubMedGoogle Scholar
- Larue L, Antos C, Butz S, Huber O, Delmas V, Dominis M, Kemler R: A role for cadherins in tissue formation. Development. 1996, 122: 3185-3194.PubMedGoogle Scholar
- Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW: Controlled, scalable embryonic stem cell differentiation culture. Stem Cells. 2004, 22: 275-282. 10.1634/stemcells.22-3-275.View ArticlePubMedGoogle Scholar
- Eastham AM, Spencer H, Soncin F, Ritson S, Merry CL, Stern PL, Ward CM: Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 2007, 67: 11254-11262. 10.1158/0008-5472.CAN-07-2253.View ArticlePubMedGoogle Scholar
- Ullmann U, In't Veld P, Gilles C, Sermon K, De Rycke M, Van de Velde H, Van Steirteghem A, Liebaers I: Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod. 2007, 13: 21-32. 10.1093/molehr/gal091.View ArticlePubMedGoogle Scholar
- Nagaoka M, Koshimizu U, Yuasa S, Hattori F, Chen H, Tanaka T, Okabe M, Fukuda K, Akaike T: E-cadherin-coated plates maintain pluripotent ES cells without colony formation. PLoS ONE. 2006, 1: e15-10.1371/journal.pone.0000015.PubMed CentralView ArticlePubMedGoogle Scholar
- Nagaoka M, Hagiwara Y, Takemura K, Murakami Y, Li J, Duncan SA, Akaike T: Design of the artificial acellular feeder layer for the efficient propagation of mouse embryonic stem cells. J Biol Chem. 2008, 283: 26468-26476. 10.1074/jbc.M805037200.PubMed CentralView ArticlePubMedGoogle Scholar
- Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA: Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 2006, 24: 185-187. 10.1038/nbt1177.View ArticlePubMedGoogle Scholar
- Rosler ES, Fisk GJ, Ares X, Irving J, Miura T, Rao MS, Carpenter MK: Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn. 2004, 229: 259-274. 10.1002/dvdy.10430.View ArticlePubMedGoogle Scholar
- Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA: Highly Efficient Generation of Human Hepatocyte-like Cells from Induced Pluripotent Stem Cells. Hepatology. 2009, 51: 297-305. 10.1002/hep.23354.View ArticleGoogle Scholar
- Guilak F, Cohen DM, Estes BT, Gimble JM, Liedtke W, Chen CS: Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell. 2009, 5: 17-26. 10.1016/j.stem.2009.06.016.PubMed CentralView ArticlePubMedGoogle Scholar
- Daley WP, Peters SB, Larsen M: Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci. 2008, 121: 255-264. 10.1242/jcs.006064.View ArticlePubMedGoogle Scholar
- Ilic D: Culture of human embryonic stem cells and the extracellular matrix microenvironment. Regen Med. 2006, 1: 95-101. 10.2217/174607184.108.40.206.View ArticlePubMedGoogle Scholar
- Hayashi Y, Furue MK, Okamoto T, Ohnuma K, Myoishi Y, Fukuhara Y, Abe T, Sato JD, Hata R, Asashima M: Integrins regulate mouse embryonic stem cell self-renewal. Stem Cells. 2007, 25: 3005-3015. 10.1634/stemcells.2007-0103.View ArticlePubMedGoogle Scholar
- Domogatskaya A, Rodin S, Boutaud A, Tryggvason K: Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro. Stem Cells. 2008, 26: 2800-2809. 10.1634/stemcells.2007-0389.View ArticlePubMedGoogle Scholar
- Braam SR, Zeinstra L, Litjens S, Ward-van Oostwaard D, van den Brink S, van Laake L, Lebrin F, Kats P, Hochstenbach R, Passier R, Sonnenberg A, Mummery CL: Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells. 2008, 26: 2257-2265. 10.1634/stemcells.2008-0291.View ArticlePubMedGoogle Scholar
- Furue MK, Na J, Jackson JP, Okamoto T, Jones M, Baker D, Hata R, Moore HD, Sato JD, Andrews PW: Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci USA. 2008, 105: 13409-13414. 10.1073/pnas.0806136105.PubMed CentralView ArticlePubMedGoogle Scholar
- Miyazaki T, Futaki S, Hasegawa K, Kawasaki M, Sanzen N, Hayashi M, Kawase E, Sekiguchi K, Nakatsuji N, Suemori H: Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells. Biochem Biophys Res Commun. 2008, 375: 27-32. 10.1016/j.bbrc.2008.07.111.View ArticlePubMedGoogle Scholar
- Dedhar S: Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol. 2000, 12: 250-256. 10.1016/S0955-0674(99)00083-6.View ArticlePubMedGoogle Scholar
- De Santis G, Miotti S, Mazzi M, Canevari S, Tomassetti A: E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene. 2009, 28: 1206-1217. 10.1038/onc.2008.470.View ArticlePubMedGoogle Scholar
- Watanabe S, Umehara H, Murayama K, Okabe M, Kimura T, Nakano T: Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene. 2006, 25: 2697-2707. 10.1038/sj.onc.1209307.View ArticlePubMedGoogle Scholar
- Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I, Peters H, Walter T, Stojkovic P, Evans J, Stojkovic M, Lako M: The role of PI3K/AKT, MAPK/ERK and NF-κB signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet. 2006, 15: 1894-1913. 10.1093/hmg/ddl112.View ArticlePubMedGoogle Scholar
- Soncin F, Mohamet L, Eckardt D, Ritson S, Eastham AM, Bobola N, Russell A, Davies S, Kemler R, Merry CL, Ward CM: Abrogation of E-cadherin-Mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal. Stem Cells. 2009, 27: 2069-2080. 10.1002/stem.134.View ArticlePubMedGoogle Scholar
- Ginis I, Luo Y, Miura T, Thies S, Brandenberger R, Gerecht-Nir S, Amit M, Hoke A, Carpenter MK, Itskovitz-Eldor J, Rao MS: Differences between human and mouse embryonic stem cells. Dev Biol. 2004, 269: 360-380. 10.1016/j.ydbio.2003.12.034.View ArticlePubMedGoogle Scholar
- Harb N, Archer TK, Sato N: The Rho-Rock-Myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cells. PLoS One. 2008, 3: e3001-10.1371/journal.pone.0003001.PubMed CentralView ArticlePubMedGoogle Scholar
- Nagaoka M, Akaike T: Single amino acid substitution in the mouse IgG1 Fc region induces drastic enhancement of the affinity to protein A. Protein Eng. 2003, 16: 243-245. 10.1093/proeng/gzg037.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.